Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ISRCTN16037920) titled 'A study comparing two WHO recommended all oral shorter treatment regimens for pre-extensively drug resistant tuberculosis: evaluating their effectiveness, cost-effectiveness, and implementation outcomes in Pakistan setting' on Aug. 11.
Study Type: Interventional
Study Design:
Randomized controlled non-inferiority trial (Treatment)
Primary Sponsor: Association for Social Development
Condition:
Pre-extensively drug resistant tuberculosis (pre-XDR TB)
Infections and Infestations
Intervention:
Intervention arm regimen: BDLC
Participants in the intervention arm will receive the BDLC regimen, which includes:
* B...